1. Home
  2. UG vs ESLA Comparison

UG vs ESLA Comparison

Compare UG & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.12

Market Cap

27.7M

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.59

Market Cap

48.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
ESLA
Founded
1942
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
48.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UG
ESLA
Price
$6.12
$1.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
12.6K
128.7K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
11.44%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$10,060,322.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$0.73
52 Week High
$11.98
$3.15

Technical Indicators

Market Signals
Indicator
UG
ESLA
Relative Strength Index (RSI) 49.17 43.45
Support Level $6.08 $1.46
Resistance Level $6.25 $1.80
Average True Range (ATR) 0.11 0.23
MACD 0.06 -0.03
Stochastic Oscillator 65.79 24.00

Price Performance

Historical Comparison
UG
ESLA

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: